Cd44 Targeted Delivery of Hyaluronic Acid-Coated Polymeric Nanoparticles Against Colorectal Cancer

References

• Buccafusca G , ProserpioI, TralongoACet al. Early colorectal cancer: diagnosis, treatment and survivorship care. Crit. Rev. Oncol. Hematol.136, 20–30 (2019).
   PubMed Web of Science ®Google Scholar
• Teixido C , CastilloP, Martinez-VilaCet al. Molecular markers and targets in melanoma. Cells10(9), 2320 (2021).
   PubMed Web of Science ®Google Scholar
• Sarandria N . A literature review in immuno-oncology: pathophysiological and clinical features of colorectal cancer and the role of the doctor–patient interaction. J. Cancer Ther.13(12), 654–684 (2022).
   Google Scholar
• Lewandowska A , ReligioniU, CzerwAet al. Nutritional treatment of patients with colorectal cancer. Int. J. Environ. Res. Public Health19(11), 6881 (2022).
   PubMed Web of Science ®Google Scholar
• Chavda J , BhattH. Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer. Eur. J. Med. Chem.206, 112675 (2020).
   PubMed Web of Science ®Google Scholar
• Yosef H , FrickT, HammoudMet al. Exploring the efficacy and cellular uptake of sorafenib in colon cancer cells by Raman micro-spectroscopy. Analyst143(24), 6069–6078 (2018).
   PubMed Web of Science ®Google Scholar
• Ahiwale RJ , ChellampillaiB, PawarAP. Investigation of novel sorafenib tosylate loaded biomaterial based nano-cochleates dispersion system for treatment of hepatocellular carcinoma. J. Dispersion Sci. Technol.43(10), 1568–1586 (2022).
   Web of Science ®Google Scholar
• Pratt RL . Hyaluronan and the fascial frontier. Int. J. Mol. Sci.22(13), 6845 (2021).
   PubMed Web of Science ®Google Scholar
• Castaño-Amores C , Nieto-GómezP, Nieto-SánchezMT, Álvarez-SánchezR. Práctica clínica en prevención de migraña con anticuerpos monoclonales del péptido relacionado con el gen calcitonina: evidencias de casos reales. Ars Pharmaceutica63(4), 311–319 (2022).
   Google Scholar
• Lee SY , KangMS, JeongWYet al. Hyaluronic acid-based theranostic nanomedicines for targeted cancer therapy. Cancers12(4), 940 (2020).
   PubMed Web of Science ®Google Scholar
• Settanni G , SchäferT, MuhlCet al. Poly-sarcosine and poly (ethylene-glycol) interactions with proteins investigated using molecular dynamics simulations. Comput. Struct. Biotechnol. J.16, 543–550 (2018).
   PubMed Web of Science ®Google Scholar
• Wu F , ZhouY, LiLet al. Computational approaches in preclinical studies on drug discovery and development. Front. Chem.8, 726 (2020).
   PubMed Web of Science ®Google Scholar
• Tiwari A , ModiSJ, GabheSY, KulkarniVM. Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT). Bioorg. Chem.110, 1–17 (2021).
   Web of Science ®Google Scholar
• Dhawan V , LokrasA, JoshiGet al. Polysaccharide and monosaccharide guided liver delivery of sorafenib tosylate –a nano-strategic approach and comparative assessment of hepatospecificity. Int. J. Pharm.625, 1–16 (2022).
   Google Scholar
• Giammona G , DragoSE, CalabreseGet al. Galactosylated polymer/gold nanorods nanocomposites for sustained and pulsed chemo-photothermal treatments of hepatocarcinoma. Pharmaceutics14(11), 2503 (2022).
   PubMed Web of Science ®Google Scholar
• Bhattacharya S , AnjumMM, PatelKK. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery. Drug Deliv.29(1), 1060–1074 (2022).
   PubMed Web of Science ®Google Scholar
• Almoustafa HA , AlshawshMA, Al-SuedeFSRet al. The chemotherapeutic efficacy of hyaluronic acid coated polymeric nanoparticles against breast cancer metastasis in female NCr-Nu/Nu nude mice. Polymers15(2), 284 (2023).
   PubMed Web of Science ®Google Scholar
• Kale SA , ShaikhKS. Validated UV-vis spectrophotometric method for the estimation of sorafenib tosylate in bulk and nanoparticles. Int. J. Health Sci.6(Suppl. 3), 4011–4019 (2022).
   Google Scholar
• Dahiya M , AwasthiR, DuaK, DurejaH. Sorafenib tosylate loaded superparamagnetic nanoparticles: development, optimization and cytotoxicity analysis on HepG2 human hepatocellular carcinoma cell line. J. Drug Deliv. Sci. Technol.79, 1–19 (2023).
   Web of Science ®Google Scholar
• Li N , ChenY, SunHet al. Decreasing acute toxicity and suppressing colorectal carcinoma using sorafenib-loaded nanoparticles. Pharm. Dev. Technol.25(5), 556–565 (2020).
   PubMed Web of Science ®Google Scholar
• Caputo TM , CusanoAM, PrincipeSet al. Sorafenib-loaded PLGA carriers for enhanced drug delivery and cellular uptake in liver cancer cells. Int. J. Nanomed.18, 4121–4142 (2023).
   PubMed Web of Science ®Google Scholar
• Shukla SK , KulkarniNS, FarralesPet al. Sorafenib loaded inhalable polymeric nanocarriers against non-small-cell lung cancer. Pharm. Res.37, 1–19 (2020).
   Web of Science ®Google Scholar
• Gao X , JiangP, ZhangQet al. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma. J. Exp. Clin. Cancer Res.38(1), 1–15 (2019).
   PubMed Web of Science ®Google Scholar
• Wu H , WangC, SunJet al. Self-assembled and self-monitored sorafenib/indocyanine green nanodrug with synergistic antitumor activity mediated by hyperthermia and reactive oxygen species-induced apoptosis. ACS Appl. Mater. Interfaces11(47), 43996–44006 (2019).
   PubMed Web of Science ®Google Scholar
• Poojari R , SawantAV, KiniSet al. Antihepatoma activity of multifunctional polymeric nanoparticles via inhibition of microtubules and tyrosine kinases. Nanomedicine15(04), 381–396 (2020).
   PubMedGoogle Scholar
• Varshosaz J , SadriF, RostamiMet al. Synthesis of pectin-deoxycholic acid conjugate for targeted delivery of anticancer drugs in hepatocellular carcinoma. Int. J. Biol. Macromol.139, 665–677 (2019).
   PubMed Web of Science ®Google Scholar
• Palomba F , GenoveseD, RampazzoEet al. PluS nanoparticles loaded with sorafenib: synthetic approach and their effects on endothelial cells. ACS Omega4(9), 13962–13971 (2019).
   PubMed Web of Science ®Google Scholar
• Sarwar U , NaeemM, NurjisFet al. Ultrasound-mediated in vivo biodistribution of coumarin-labeled sorafenib-loaded liposome-based nanotheranostic system. Nanomedicine17(25), 1909–1927 (2022).
   PubMed Web of Science ®Google Scholar
• Gopakumar L , SreeranganathanM, ChappanSet al. Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core–shell protein nanoparticle. Drug Deliv. Transl. Res.12(11), 2824–2837 (2022).
   PubMed Web of Science ®Google Scholar
• Donthi MR , MunnangiSR, KrishnaKVet al. Formulating ternary inclusion complex of sorafenib tosylate using β-cyclodextrin and hydrophilic polymers: physicochemical characterization and in vitro assessment. AAPS PharmSciTech23(7), 254 (2022).
   PubMed Web of Science ®Google Scholar
• Xiao B , HanMK, ViennoisEet al. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale7(42), 17745–17755 (2015).
   PubMed Web of Science ®Google Scholar
• Bertrand N , WuJ, XuXet al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev.66, 2–25 (2014).
   PubMed Web of Science ®Google Scholar
• Babos G , BiróE, MeiczingerM, FeczkóT. Dual drug delivery of sorafenib and doxorubicin from PLGA and PEG-PLGA polymeric nanoparticles. Polymers10(8), 895 (2018).
   PubMed Web of Science ®Google Scholar
• Abdellatif AA , AliAT, BouazzaouiAet al. Formulation of polymeric nanoparticles loaded sorafenib; evaluation of cytotoxicity, molecular evaluation, and gene expression studies in lung and breast cancer cell lines. Nanotechnol. Rev.11(1), 987–1004 (2022).
   Web of Science ®Google Scholar
• Kalepu S , NekkantiV. Improved delivery of poorly soluble compounds using nanoparticle technology: a review. Drug Deliv. Transl. Res.6, 319–332 (2016).
   PubMed Web of Science ®Google Scholar
• Poojari R , KiniS, SrivastavaR, PandaD. Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells. Colloids Surf. B Biointerfaces143, 131–138 (2016).
   PubMed Web of Science ®Google Scholar
• Guan Q , GuoR, HuangSet al. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy. J. Control. Rel.320, 392–403 (2020).
   PubMed Web of Science ®Google Scholar
• Hu B , SunD, SunCet al. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem. Biophys. Res. Commun.468(4), 525–532 (2015).
   PubMed Web of Science ®Google Scholar
• Bahman A , AbazaM-S, KhoushaishS, Al-AttiyahRJ. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells. BMC Complement. Med. Ther.23(1), 1–24 (2023).
   Google Scholar
• Chen Y , LiN, XuBet al. Polymer-based nanoparticles for chemo/gene-therapy: evaluation its therapeutic efficacy and toxicity against colorectal carcinoma. Biomed. Pharmacother.118, 1–19 (2019).
   Web of Science ®Google Scholar
• Lazzari S , MoscatelliD, CodariFet al. Colloidal stability of polymeric nanoparticles in biological fluids. J. Nanoparticle Res.14, 1–10 (2012).
   PubMed Web of Science ®Google Scholar
• Fanciullino R , CiccoliniJ, MilanoG. Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs. Crit. Rev. Oncol. Hematol.88(3), 504–513 (2013).
   PubMed Web of Science ®Google Scholar